AbbVie <ABBV.N>: Leerink Partners raises target price to $279 from $245
ABBV•Related News
Lockheed demonstrates rapidly retrainable AI sonar system SensorMAX for submarine detection at RIMPAC 2026
LMT•
Kratos Defense jumps after Q2 beat-and-raise report
KTOS•
Copper hits 12-week high as stocks outside US tighten
XLB•
Donnelley Financial Solutions releases transcript of Q2 2026 earnings call
DFIN•
Amgen jolts to record-high after hiking FY forecasts, Q2 results beat
AMGN•